Investigative Ophthalmology & Visual Science Cover Image for Volume 64, Issue 8
June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Introduction to myopia control treatments including optical, light and pharmacological treatments
Author Affiliations & Notes
  • Kate Gifford
    Queensland University of Technology Faculty of Health, Kelvin Grove, Queensland, Australia
  • Footnotes
    Commercial Relationships   Kate Gifford CooperVision, EssilorLuxottica, Hoya Vision, Johnson & Johnson Vision, Menicon, SightGlass Vision, Visioneering Technologies, Vyluma, Code C (Consultant/Contractor)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 16. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Kate Gifford; Introduction to myopia control treatments including optical, light and pharmacological treatments. Invest. Ophthalmol. Vis. Sci. 2023;64(8):16.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Presentation Description : A number of treatments are currently available to eye care providers that can, at least partially, control the progression of myopia in most children. These treatments include optical (spectacles with peripheral designs, multizone contact lenes and orthokeratology), pharmacological (low dose atropine eye drops), and light therapies. This talk will briefly introduce the available treatments and the current knowledge of their efficacy.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×